These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1269 related items for PubMed ID: 24121219
1. [Treatment outcome in primary testicular non-Hodgkin lymphoma]. Iványi JL, Marton E, Plander M, Engert ZV, Tóth C. Orv Hetil; 2013 Oct 20; 154(42):1666-73. PubMed ID: 24121219 [Abstract] [Full Text] [Related]
2. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C. Orv Hetil; 2009 Oct 18; 150(42):1937-44. PubMed ID: 19812012 [Abstract] [Full Text] [Related]
3. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. Touroutoglou N, Dimopoulos MA, Younes A, Hess M, Pugh W, Cox J, Cabanillas F, Sarris AH. J Clin Oncol; 1995 Jun 18; 13(6):1361-7. PubMed ID: 7751880 [Abstract] [Full Text] [Related]
4. Single-center experience in the treatment of primary testicular lymphoma. Mihaljevic B, Vukovic V, Smiljanic M, Milic N, Todorovic M, Bila J, Andjelic B, Djurasinovic V, Jelicic J, Antic D. Oncol Res Treat; 2014 Jun 18; 37(5):239-42. PubMed ID: 24853782 [Abstract] [Full Text] [Related]
5. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial. Vitolo U, Chiappella A, Ferreri AJ, Martelli M, Baldi I, Balzarotti M, Bottelli C, Conconi A, Gomez H, Lopez-Guillermo A, Martinelli G, Merli F, Novero D, Orsucci L, Pavone V, Ricardi U, Storti S, Gospodarowicz MK, Cavalli F, Sarris AH, Zucca E. J Clin Oncol; 2011 Jul 10; 29(20):2766-72. PubMed ID: 21646602 [Abstract] [Full Text] [Related]
6. Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group. Linassier C, Desablens B, Lefrancq T, Le Prise PY, Harousseau JL, Jacob C, Gandhour C, Haillot O, Lucas V, Leloup R, Escoffre M, Colombat P, Tabuteau S, GOELAMS Study Group. Clin Lymphoma; 2002 Dec 10; 3(3):167-72. PubMed ID: 12521394 [Abstract] [Full Text] [Related]
7. Efficacy of prophylactic irradiation to the contralateral testis for patients with advanced-stage primary testicular lymphoma: an analysis of outcomes at a single institution. Tokiya R, Yoden E, Konishi K, Kamitani N, Hiratsuka J, Koresawa R, Hirose T, Sano F, Tokunaga H, Kondo T, Wada H, Sugihara T. Int J Hematol; 2017 Oct 10; 106(4):533-540. PubMed ID: 28612278 [Abstract] [Full Text] [Related]
8. Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study. Zouhair A, Weber D, Belkacémi Y, Ketterer N, Dietrich PY, Villà S, Scandolaro L, Bieri S, Studer G, Delacretaz F, Girardet C, Mirimanoff RO, Ozsahin M, Rare Cancer Network. Int J Radiat Oncol Biol Phys; 2002 Mar 01; 52(3):652-6. PubMed ID: 11849786 [Abstract] [Full Text] [Related]
9. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Pfreundschuh M, Kuhnt E, Trümper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, López-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N, MabThera International Trial (MInT) Group. Lancet Oncol; 2011 Oct 01; 12(11):1013-22. PubMed ID: 21940214 [Abstract] [Full Text] [Related]
10. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients. Zimmermann H, Reinke P, Neuhaus R, Lehmkuhl H, Oertel S, Atta J, Planker M, Gärtner B, Lenze D, Anagnostopoulos I, Riess H, Trappe RU. Cancer; 2012 Oct 01; 118(19):4715-24. PubMed ID: 22392525 [Abstract] [Full Text] [Related]
12. Rituximab plus a CHOP-like regimen, central nervous system prophylaxis, and contralateral testicular irradiation for localized primary testicular diffuse large B-cell lymphoma lead to prolonged progression-free survival. Ichikawa K, Noguchi M, Koike M, Aritaka N, Sekiguchi Y, Sunami Y, Tsutsui M, Hosone M, Hirano T, Gotoh A, Komatsu N. Int J Hematol; 2014 Oct 01; 100(4):370-8. PubMed ID: 25085255 [Abstract] [Full Text] [Related]